Antibacterial Activity of Long-Chain Polyunsaturated Fatty Acids against Propionibacterium acnes and Staphylococcus aureus

New compounds are needed to treat acne and superficial infections caused by Propionibacterium acnes and Staphylococcus aureus due to the reduced effectiveness of agents used at present. Long-chain polyunsaturated fatty acids (LC-PUFAs) are attracting attention as potential new topical treatments for Gram-positive infections due to their antimicrobial potency and anti-inflammatory properties. This present study aimed to investigate the antimicrobial effects of six LC-PUFAs against P. acnes and S. aureus to evaluate their potential to treat infections caused by these pathogens. Minimum inhibitory concentrations were determined against P. acnes and S. aureus, and the LC-PUFAs were found to inhibit bacterial growth at 32–1024 mg/L. Generally, P. acnes was more susceptible to the growth inhibitory actions of LC-PUFAs, but these compounds were bactericidal only for S. aureus. This is the first report of antibacterial activity attributed to 15-hydroxyeicosapentaenoic acid (15-OHEPA) and 15-hydroxyeicosatrienoic acid (HETrE), while the anti-P. acnes effects of the six LC-PUFAs used herein are novel observations. During exposure to the LC-PUFAs, S. aureus cells were killed within 15–30 min. Checkerboard assays demonstrated that the LC-PUFAs did not antagonise the antimicrobial potency of clinical agents used presently against P. acnes and S. aureus. However, importantly, synergistic interactions against S. aureus were detected for combinations of benzoyl peroxide with 15-OHEPA, dihomo-γ-linolenic acid (DGLA) and HETrE; and neomycin with 15-OHEPA, DGLA, eicosapentaenoic acid, γ-linolenic acid and HETrE. In conclusion, LC-PUFAs warrant further evaluation as possible new agents to treat skin infections caused by P. acnes and S. aureus, especially in synergistic combinations with antimicrobial agents already used clinically.

[1]  T. Kristmundsdottir,et al.  Lipids as Active Ingredients in Pharmaceuticals, Cosmetics and Health Foods , 2010 .

[2]  Yu-Tseung Liu,et al.  An innate bactericidal oleic acid effective against skin infection of methicillin-resistant Staphylococcus aureus: a therapy concordant with evolutionary medicine. , 2011, Journal of microbiology and biotechnology.

[3]  Gerard D. Wright,et al.  Antibiotic adjuvants: multicomponent anti-infective strategies , 2011, Expert Reviews in Molecular Medicine.

[4]  Chun-Ming Huang,et al.  Histone H4 is a major component of the antimicrobial action of human sebocytes. , 2009, The Journal of investigative dermatology.

[5]  S. Foster,et al.  The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. , 2007, Cell host & microbe.

[6]  A. Upton,et al.  Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. , 2003, The Journal of antimicrobial chemotherapy.

[7]  F. Odds,et al.  Synergy, antagonism, and what the chequerboard puts between them. , 2003, The Journal of antimicrobial chemotherapy.

[8]  H. Thormar,et al.  The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. , 2007, Chemistry and physics of lipids.

[9]  Disciplinary Committee,et al.  Royal Pharmaceutical Society of Great Britain , 2002 .

[10]  R. Cox,et al.  Use of mouse models in studying type 2 diabetes mellitus , 2010, Expert Reviews in Molecular Medicine.

[11]  H. Coutinho,et al.  Synergistic action between Caryocar coriaceum Wittm. fixed oil with aminoglycosides in vitro , 2011 .

[12]  J. Harper.  An update on the pathogenesis and management of acne vulgaris. , 2004, Journal of the American Academy of Dermatology.

[13]  H. Sasaki,et al.  In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA). , 2006, International journal of antimicrobial agents.

[14]  W. Gregory,et al.  Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A7 2007 , 2012 .

[15]  C. Gemmell,et al.  In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. , 2010, International journal of antimicrobial agents.

[16]  S. Kang,et al.  Antibacterial activity of eicosapentaenoic acid (EPA) against foodborne and food spoilage microorganisms , 2007 .

[17]  H. Knapp,et al.  Bactericidal effects of polyunsaturated fatty acids. , 1986, The Journal of infectious diseases.

[18]  A. Desbois,et al.  Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential , 2010, Applied Microbiology and Biotechnology.

[19]  A. B. Prasad,et al.  British National Formulary , 1994 .

[20]  L. Decker,et al.  Role of lipids in augmenting the antibacterial activity of benzoyl peroxide against Propionibacterium acnes , 1989, Antimicrobial Agents and Chemotherapy.

[21]  M. Dramaix,et al.  Treatment of acne with topical antibiotics: lessons from clinical studies , 2005, The British journal of dermatology.

[22]  L. Chaudhary,et al.  Metabolism of polyunsaturated fatty acids and their toxicity to the microflora of the rumen , 2007, Antonie van Leeuwenhoek.

[23]  P. Wertz,et al.  The Emerging Role of Peptides and Lipids as Antimicrobial Epidermal Barriers and Modulators of Local Inflammation , 2012, Skin Pharmacology and Physiology.

[24]  K. T. Holland,et al.  Acne and Propionibacterium acnes. , 2004, Clinics in dermatology.

[25]  S. Kang,et al.  Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria. , 2007, International journal of food microbiology.

[26]  Deborah V Dawson,et al.  Thematic Review Series: Skin Lipids. Antimicrobial lipids at the skin surface Published, JLR Papers in Press, September 28, 2007. , 2008, Journal of Lipid Research.

[27]  A. M. Kayastha,et al.  Antibacterial potential of γ-linolenic acid from Fischerella sp. colonizing Neem tree bark , 2006 .

[28]  J. E. Kim,et al.  Antibiotic resistance of microbial strains isolated from Korean acne patients , 2012, The Journal of dermatology.

[29]  Coonrod Jd.  Rôle of surfactant free fatty acids in antimicrobial defenses. , 1987 .

[30]  W. Lusby,et al.  Antimicrobial activity of fatty acids against Bacillus larvae, the causative agent of American foulbrood disease. , 1993 .

[31]  J. Ebersole,et al.  A novel bioactivity of omega-3 polyunsaturated fatty acids and their ester derivatives. , 2010, Molecular oral microbiology.

[32]  P. Elias,et al.  Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. , 2001, The Journal of investigative dermatology.

[33]  David R. Drake,et al.  Antimicrobial lipids at the skin surface , 2007 .

[34]  L. Garcia.  Synergism Testing: Broth Microdilution Checkerboard and Broth Macrodilution Methods , 2010 .

[35]  G. Butcher,et al.  Sensitivity of Staphylococcus aureus to unsaturated fatty acids. , 1976, Journal of general microbiology.

[36]  Andrew P. Desbois,et al.  Antimicrobial Properties of Eicosapentaenoic Acid (C20 : 5n3) , 2013 .

[37]  MH Motswaledi.  Superficial skin infections and the use of topical and systemic antibiotics in general practice , 2011 .

[38]  Bradley G. Mehrtens,et al.  Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 18Z , 1991, Infection and immunity.

[39]  K. Venkitanarayanan,et al.  Antibacterial effect of caprylic acid and monocaprylin on major bacterial mastitis pathogens. , 2005, Journal of dairy science.

[40]  J. Coonrod.  Rôle of surfactant free fatty acids in antimicrobial defenses. , 1987, European journal of respiratory diseases. Supplement.

[41]  J. Wille,et al.  Palmitoleic Acid Isomer (C16:1Δ6) in Human Skin Sebum Is Effective against Gram-Positive Bacteria , 2003, Skin Pharmacology and Physiology.

[42]  V. Wu,et al.  Quantitative structure-activity relationships of antimicrobial fatty acids and derivatives against Staphylococcus aureus , 2012, Journal of Zhejiang University SCIENCE B.

[43]  C. Huang,et al.  Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms. , 2010, Archives of oral biology.

[44]  J. Blondeau.  New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. , 2009, Veterinary dermatology.

[45]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[46]  A. Mearns-Spragg,et al.  A Fatty Acid from the Diatom Phaeodactylum tricornutum is Antibacterial Against Diverse Bacteria Including Multi-resistant Staphylococcus aureus (MRSA) , 2008, Marine Biotechnology.

[47]  J. Q. Rosso,et al.  Antimicrobial Property of Lauric Acid Against Propionibacterium Acnes: Its Therapeutic Potential for Inflammatory Acne Vulgaris , 2011 .

[48]  Chun-Ming Huang,et al.  Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. , 2011, Biomaterials.

[49]  H. Roche,et al.  Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. , 2010, The Journal of nutritional biochemistry.

[50]  G. Barnathan,et al.  Fatty acids from lipids of marine organisms: molecular biodiversity, roles as biomarkers, biologically active compounds, and economical aspects. , 2005, Advances in Biochemical Engineering/Biotechnology.

[51]  A. Kearns,et al.  Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area. , 2004, The Journal of antimicrobial chemotherapy.

[52]  Andrew P. Desbois,et al.  Potential applications of antimicrobial fatty acids in medicine, agriculture and other industries. , 2012, Recent patents on anti-infective drug discovery.

[53]  V. Nizet,et al.  A Toll-Like Receptor 2-Responsive Lipid Effector Pathway Protects Mammals against Skin Infections with Gram-Positive Bacteria , 2005, Infection and Immunity.

[54]  P. Heczko,et al.  Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids. , 1978, The Journal of investigative dermatology.

[55]  D. Torgerson,et al.  Systematic review of topical treatments for fungal infections of the skin and nails of the feet , 1999, BMJ.

[56]  J. Baker,et al.  In Vitro Antibacterial Activity of NB-003 against Propionibacterium acnes , 2011, Antimicrobial Agents and Chemotherapy.

[57]  E. Giamarellos‐Bourboulis,et al.  Impact of n-6 Polyunsaturated Fatty Acids on Growth of Multidrug-Resistant Pseudomonas aeruginosa: Interactions with Amikacin and Ceftazidime , 2000, Antimicrobial Agents and Chemotherapy.

[58]  H. Thormar,et al.  Killing of Gram‐positive cocci by fatty acids and monoglycerides Note , 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.